SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ribi Immunochem (ribi)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: needawin who wrote (82)9/8/1998 2:18:00 PM
From: tom jones  Read Replies (1) of 92
 
To all: I spoke with investor relations on September 2. They said results for SmithKline Beecham's herpes vaccine with Ribi's adjuvant will be out near the end of the year.
The construction to be done to get Melacine approval will be done in October and inspection in November.
So if we get good news on both of these we will have some happy holidays, but then something may come up to delay the news.
Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News